| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/18/2011 | WO2011099507A1 Salt of fused heterocyclic derivative and crystal thereof |
| 08/18/2011 | WO2011098262A2 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth |
| 08/18/2011 | WO2011069795A4 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 08/18/2011 | WO2011029547A3 Pregnane derivatives condensed in the 16, 17 position with an n-substituted isoxazolidine ring as anti-inflammatory agents |
| 08/18/2011 | US20110201656 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 08/18/2011 | US20110201586 Pharmaceutical composition and method for treating hypogonadism |
| 08/18/2011 | US20110201579 Method of Improving the Overall Health of a Patient by Application of Pregnenolone |
| 08/18/2011 | US20110201554 Hfsh aqueous formulation |
| 08/18/2011 | US20110201551 Peptide having anti-diabetic activity and use thereof |
| 08/18/2011 | US20110200679 Method for manufacturing sustained release microsphere by solvent flow evaporation method |
| 08/18/2011 | US20110200623 Polypeptide complex comprising non-peptidyl polymer having three functional ends |
| 08/18/2011 | CA2789240A1 Progesterone receptor antagonists |
| 08/18/2011 | CA2789237A1 Progesterone receptor antagonists |
| 08/18/2011 | CA2788533A1 Salt of fused heterocyclic derivative and crystal thereof |
| 08/17/2011 | EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/17/2011 | EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation |
| 08/17/2011 | EP2356227A2 Encapsulation of pancreatic cells derived from human pluripotent stem cells |
| 08/17/2011 | EP2355838A2 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| 08/17/2011 | EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 08/17/2011 | CN1829511B Use of telmisartan and amlodipine or Nifedipine in preparing medicine for increasing insulin sensitivity |
| 08/17/2011 | CN1715926B Use of neuregulin mutant |
| 08/17/2011 | CN1637416B Labelled growth hormone secretagogue and its synthesis method and uses |
| 08/17/2011 | CN102159548A Amide compounds useful in therapy |
| 08/17/2011 | CN102159539A A new metformin glycinate salt for blood glucose control |
| 08/17/2011 | CN102153538A Benzocyclodirivative |
| 08/17/2011 | CN102151337A Compositions and methods for regulated protein expression in gut |
| 08/17/2011 | CN101745067B Compound garden burnet and hairyvein agrimony soup for treating dysfunctional uterine bleeding (DUB) |
| 08/17/2011 | CN101511367B Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 08/17/2011 | CN101406460B Euthyrox tablet |
| 08/17/2011 | CN101218245B 3-ester prodrugs of ethynylestradiol |
| 08/17/2011 | CN101080395B Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
| 08/16/2011 | US7999109 CCR9 inhibitors and methods of use thereof |
| 08/16/2011 | CA2468248C Pregnane steroids for use in the treatment of cns disorders |
| 08/11/2011 | WO2011096490A1 Imidazopyridin-2-one derivative |
| 08/11/2011 | WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | WO2011095535A2 Pyrrolidine derivatives |
| 08/11/2011 | WO2011095495A1 Compositions and methods for inhibiting expression of ikk2 genes |
| 08/11/2011 | US20110196045 Estrogenic compounds, process for their production and pharmaceutical uses thereof |
| 08/11/2011 | US20110196013 Animal feed composition |
| 08/11/2011 | US20110195942 Method of making and using 7alpha, 11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoate |
| 08/11/2011 | US20110195900 Peptidic pth receptor agonists |
| 08/11/2011 | US20110195114 Transdermal delivery systems for active agents |
| 08/11/2011 | US20110195080 Compositions and Methods for Enhanced Somatostatin Immunogenicity in the Treatment of Growth Hormone and Insulin-Like Growth Factor One Deficiency |
| 08/11/2011 | US20110195063 Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor |
| 08/11/2011 | CA2788986A1 Pyrrolidine derivatives |
| 08/11/2011 | CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/10/2011 | EP1973524B1 Concentrated liquid thyroid hormone composition |
| 08/10/2011 | CN1817906B Antibody against human parathormone related peptides |
| 08/10/2011 | CN1551878B 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 08/10/2011 | CN102145128A Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof |
| 08/10/2011 | CN102145041A Pharmaceutical composition with function of treating polycystic ovary syndrome |
| 08/10/2011 | CN102145027A Pollen pini water extract for treating child sexual precocity, preparation method and use of pollen pini water extract |
| 08/09/2011 | CA2434484C Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances |
| 08/09/2011 | CA2428039C Serotonergic agents |
| 08/09/2011 | CA2380058C Novel peptides |
| 08/09/2011 | CA2367360C Insulin-like growth factor binding protein-4 protease |
| 08/04/2011 | WO2011094632A1 Method for administration of insulin and pharmaceutical composition thereof |
| 08/04/2011 | WO2011092127A1 14,17-bridged estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 08/04/2011 | WO2010127237A3 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110189300 siRNA SILENCING OF APOLIPOPROTEIN B |
| 08/04/2011 | US20110189241 Process For Controlling The Particle Size of A [3-(Trifluoromethyl)Phenyl]-1-Aminopropane Derivative |
| 08/04/2011 | US20110189158 Clostridial neurotoxins with altered persistency |
| 08/04/2011 | US20110189124 Methods for refolding proteins containing free cysteine residues |
| 08/04/2011 | US20110189082 Human gm-csf antigen binding proteins |
| 08/03/2011 | EP2350266A1 Method for treating or preventing a pancreatic dysfunction |
| 08/03/2011 | EP2350051A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators |
| 08/03/2011 | EP2350021A1 Bridged tetrahydronaphthalene derivatives |
| 08/03/2011 | EP2350017A1 Amide compounds useful in therapy |
| 08/03/2011 | EP2349996A1 1-phenylpyrrole compounds |
| 08/03/2011 | EP2349324A2 Combination of an insulin and a glp-1 agonist |
| 08/03/2011 | EP2004168B1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists |
| 08/03/2011 | EP1480634B1 Selective androgen receptor modulators (SARMs) for treating benign prostate hyperplasia |
| 08/03/2011 | EP1446104B2 Spray drying methods |
| 08/03/2011 | CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 08/03/2011 | CN102139110A Use of angiotensin II receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 08/03/2011 | CN102138946A Birch bark extractive as well as preparation method and medical purposes thereof |
| 08/03/2011 | CN101410381B Novel 2-substituted benzimidazoles as selective androgen receptor modulators (SARMs) |
| 08/02/2011 | US7989442 (cis)-8-fluorodibenzo[b,f]pyrido[1,2-d]oxazepine-1-amine derivatives; contraception, hormone replacement therapy (HRT) or gynaecological disorders, adjuvant therapy in cancer |
| 08/02/2011 | US7988956 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 08/02/2011 | CA2583259C Aromatic ring fused pyrimidine derivative |
| 08/02/2011 | CA2449634C Somatostatin-dopamine chimeric analogs |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2107569C Parathyroid hormone receptor and dna encoding same |
| 07/28/2011 | WO2011089255A1 Growth hormones with prolonged in-vivo efficacy |
| 07/28/2011 | WO2011089250A2 Stable growth hormone compounds |
| 07/28/2011 | WO2011022596A3 Preparation of bazedoxifene and its salts |
| 07/28/2011 | WO2010083034A9 Methods for increasing adiponectin |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110183984 Small molecule inhibitors of lck sh2 domain binding |
| 07/28/2011 | US20110183928 3-Cyanoalkyl- and 3-hydroxyalkylindoles and use thereof |
| 07/28/2011 | US20110182913 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 07/28/2011 | US20110182895 Antibody variants |
| 07/28/2011 | US20110182891 Pharmaceutical dosage form comprising polymeric carrier composition |
| 07/28/2011 | CA2787895A1 Stable growth hormone compounds |
| 07/28/2011 | CA2787890A1 Growth hormones with prolonged in-vivo efficacy |
| 07/27/2011 | EP2348032A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/27/2011 | EP2348031A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |